PT-141 for women Bremelanotide has a labeled use for low sexual desire in premenopausal women
Description 5-Amino-1MQ Overview (5-amino-1-methylquinolinium), a structural analogue of methylquinolinium, is a small-molecule inhibitor of the cytosolic enzyme nicotinamide N-methyltransferase (NNMT)
The Denmark-based company announced Wednesday it had received a Complete Response Letter for dasiglucagon, which it was proposing for the ultra-rare genetic disease congenital hyperinsulinism, due to the timing of a third-party manufacturing facility reinspection. In an initial visit, the FDA had flagged deficiencies in a third-party contract manufacturer, which the company claims had been resolved by the time of a reinspection in August/September 2024
Second authorization confirmed On May 1, 2026, Health Canada authorized a second generic semaglutide injection, with the agency stating it is currently reviewing seven other submissions for generic semaglutide by different companies
Meet with a provider in-office in Hollywood, Florida or through secure telehealth